{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:16:44Z","timestamp":1773152204479,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:sec><jats:title>Aim:<\/jats:title><jats:p>To evaluate the effect of cyclosporin treatment on clinical and histological parameters in adult patients with refractory coeliac disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Thirteen patients were treated with oral cyclosporin for 2\u2003months, aiming at serum levels of 100\u2013200\u2003ng\/mL. Seven extended medication intake up to a maximum of 12\u2003months. Before and after treatment, clinical parameters were monitored and small intestinal biopsies taken. Ten of 13 patients were typed for HLA\u2010DQA1 and \u2010DQB1 alleles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Eight of 13 patients responded histologically to cyclosporin treatment. Normalization of villi was demonstrated in five patients, three after prolonged treatment. Eight patients reported a clinical response, of whom six had concomitant histological improvement. No serious side\u2010effects of cyclosporin were noticed. Nine of 10 patients who were immunogenetically typed carried the coeliac disease associated serologic DQ2 markers, one carried neither DQ2 nor DQ8 markers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>In our study group of 13 adult refractory coeliac disease patients, cyclosporin in therapeutic doses induced a histological improvement in eight patients (61%), in five of whom (38%) normalization of villi was demonstrated. Thus, we believe that cyclosporin is a therapeutic option in refractory coeliac disease, although we could not confirm earlier reports of unconditional successful treatment.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00718.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:41:49Z","timestamp":1047354109000},"page":"767-774","source":"Crossref","is-referenced-by-count":63,"title":["Cyclosporin in the treatment of adults with refractory coeliac disease\u2014an open pilot study"],"prefix":"10.1111","volume":"14","author":[{"family":"Wahab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Crusius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Uil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.54.10.783"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.65.8.909"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.41.8.886"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90423-7"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-89-4-505"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.66237000.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70530-X"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood.V92.10.3879","article-title":"Are complicated forms of celiac disease cryptic T\u2010cell lymphomas?","volume":"92","author":"Carbonnel F","year":"1998","journal-title":"Blood"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood.V93.9.3154a","article-title":"Is complicated celiac disease or refractory sprue an intestinal intra\u2010epithelial cryptic T\u2010cell lymphoma?","volume":"93","author":"Brousse N","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(67)90071-X"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1978.tb08474.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.3.333"},{"key":"e_1_2_5_14_2","first-page":"2105","article-title":"Bone disease and gluten sensitivity: time to act, to treat and to prevent","volume":"89","author":"Editorial","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.5.710"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90276-7"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.9.1215"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90312-5"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-10-199311150-00008"},{"key":"e_1_2_5_20_2","first-page":"803","article-title":"Undefined malabsorption syndrome with villous atrophy successfully reversed by treatment with cyclosporin","volume":"7","author":"Eijsbouts AMM","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199510000-00020"},{"key":"e_1_2_5_22_2","first-page":"1342","article-title":"Fatal intestinal hemorrhage complicating ileal lymphoma after cyclosporin for unresponsive celiac disease","volume":"44","author":"Gheorghe L","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199345060-00007"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.4065\/71.12.1182"},{"key":"e_1_2_5_25_2","first-page":"154","article-title":"Efficacy of cyclosporin A (CyA) in psoriasis: an overview of dose\/response, indications, contraindications and side effects","volume":"43","author":"Zachariae H","year":"1995","journal-title":"Clin Nephrol"},{"key":"e_1_2_5_26_2","first-page":"825","article-title":"1994 Consensus Conference on acute GVHD Grading","volume":"15","author":"Przepiorka D","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.6.766"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91819-P"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(95)90032-2"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.983_f.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199603000-00006"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199502000-00008"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.1.345"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.8.2766"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00718.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00718.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00718.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T13:45:03Z","timestamp":1698587103000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00718.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00718.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00718.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}